Σύγκριση μεθόδων

	Δοκιμασία Σύνδεσης Σημείων	Κλίμακα Αξιολόγησης Νόσου Alzheimer-Γνωστική Λειτουργία
Πεδίο	Νευροψυχολογία	Νευροψυχολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1958	1984
Δημιουργός	Ralph Reitan	William Rosen
Τύπος	Clinician-administered neuropsychological test of attention and executive function	Clinician-administered cognitive scale for Alzheimer's disease
Θεμελιώδης πηγή	Reitan, R. M. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8(3), 271-276.	Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141(11), 1356-1364.
Εναλλακτικές ονομασίες	TMT, Trails A, Trails B, Trail Making A	ADAS-Cog, ADAS-Cog14, ADAS-Cog13
Συναφείς	5	5
Σύνοψη	The Trail Making Test (TMT) is a simple, brief neuropsychological test developed by Reitan in 1958 that measures visuomotor processing speed, attention, and executive function. The TMT comprises two forms: Part A, which assesses basic processing speed and visual scanning, and Part B, which assesses executive function, task-switching, and cognitive flexibility. Despite its simplicity, the TMT is highly sensitive to cognitive impairment across a wide range of neurological and psychiatric conditions and remains one of the most widely used screening tests in neuropsychology.	The Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) is a clinician-administered cognitive assessment instrument designed specifically to measure cognitive decline in Alzheimer's disease. Developed by Rosen, Mohs, and Davis in 1984 and published in the American Journal of Psychiatry, the ADAS-Cog has become the gold standard outcome measure in pharmaceutical trials of antidementia drugs. It is sensitive to disease progression and capable of detecting cognitive change over periods as brief as 6–12 months.